Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 18, 2022

SELL
$50.01 - $73.35 $7.71 Million - $11.3 Million
-154,223 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$59.21 - $78.66 $9.13 Million - $12.1 Million
154,223 New
154,223 $10 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Castle Ark Alternatives, LLC Portfolio

Follow Castle Ark Alternatives, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castle Ark Alternatives, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castle Ark Alternatives, LLC with notifications on news.